RSS

Boston Scientific

Service provider Althea is now providing Boston Scientific’s implantable Watchman FLX – a left atrial appendage closure device (LAAC), to Glenfield Hospital in Leicester. Read more

News

The Boston Scientific Vercise Gevia

Hand-out Boston Scientific Corporation

The Food and Drug Administration (FDA) has approved Boston Scientific’s ImageReady MRI labelling for the Vercise Gevia Deep Brain Stimulation (DBS) system to be used in a full-body environment. Read more

News

Boston Scientific has completed the acquisition of BTG. BTG develops and commercialises products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals. Read more

News

Boston Scientific has announced results from sub-analyses of the Imperial clinical trial for the Eluvia Drug-Eluting Vascular Stent System. Read more

News

Boston Scientific has entered into a definitive agreement to acquire Vertiflex, a privately-held company which has developed and commercialised the Superion Indirect Decompression System. Read more

News

The Food and Drug Administration has approved Boston Scientific’s Vici Venous Stent System for the treatment of iliofemoral venous obstructive disease. Read more

News

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System. Read more

News

Boston Scientific has received the CE Mark and initiated a limited market release of the next generation Watchman FLX Left Atrial Appendage Closure (LAAC) Device in Europe. Read more

News

Boston Scientific has announced positive safety and efficacy results with the Luminize Radiofrequency (RF) Balloon Catheter for isolation of pulmonary veins (PV) when treating patients with atrial fibrillation (AF) at a clinical trial session. Read more

News

Boston Scientific Corporation has launched the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead. Read more

News

Medical device manufacturer Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG, which develops and commercialises products used in minimally-invasive procedures targeting cancer and vascular diseases. Read more

News

A 60 Minutes report by CBS has resurfaced claims that medical device giant, Boston Scientific, used counterfeit plastic to produce its vaginal mesh products. Read more

News